Cargando…
Cell-free plasma hypermethylated CASZ1, CDH13 and ING2 are promising biomarkers of esophageal cancer
Identifying sensitive and specific biomarkers for early detection of cancer is immensely imperative for early diagnosis and treatment and better clinical outcome of cancer patients. This study aimed to construct a specific DNA methylation pattern of cancer suppressor genes and explore the feasibilit...
Autores principales: | Wang, Huan-qiang, Yang, Cong-ying, Wang, Si-yuan, Wang, Tian, Han, Jing-ling, Wei, Kai, Liu, Fu-cun, Xu, Ji-da, Peng, Xian-zhen, Wang, Jian-ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial Department of Journal of Biomedical Research
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283827/ https://www.ncbi.nlm.nih.gov/pubmed/30355852 http://dx.doi.org/10.7555/JBR.32.20170065 |
Ejemplares similares
-
Prognostic significance of CDH13 hypermethylation and mRNA in NSCLC
por: Xue, Ruilin, et al.
Publicado: (2014) -
CASZ1b, the Short Isoform of CASZ1 Gene, Coexpresses with CASZ1a during Neurogenesis and Suppresses Neuroblastoma Cell Growth
por: Liu, Zhihui, et al.
Publicado: (2011) -
Identification of CASZ1 nuclear export signal (NES) reveals potential mechanisms for loss of CASZ1 tumor suppressor activity in neuroblastoma
por: Liu, Zhihui, et al.
Publicado: (2016) -
Integrative analysis identifies the association between CASZ1 methylation and ischemic stroke
por: Mo, Xing-Bo, et al.
Publicado: (2020) -
CDH22 hypermethylation is an independent prognostic biomarker in breast cancer
por: Martín-Sánchez, Esperanza, et al.
Publicado: (2017)